Stock Comparison
TAK vs VTRS
Takeda Pharmaceutical Co Ltd ADR and Viatris Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$50.27B
$19.02B
P/E (TTM)
—
—
Forward P/E
10.3
6.6
Price/Sales
0.0
1.3
Price/Book
1.1
1.3
EV/EBITDA
16.9
12.6
Dividend Yield
4.16%
2.99%
Profitability
Net Margin
-3.38%
-2.04%
Operating Margin
11.10%
6.78%
Return on Equity
-2.12%
-1.96%
Return on Assets
2.55%
2.31%
Growth (YoY)
Revenue Growth
3.90%
8.10%
Earnings Growth
330.20%
-70.60%
Price & Risk
Beta
0.1
0.9
52-Week High
$18.90
$17.40
52-Week Low
$12.78
$8.30
Analyst Target
$20.60
$17.81
Compare TAK and VTRS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.